drugset
drugset / Trial / NCT04785768

IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration

NCT04785768 ↗

Phase 3 Completed 1372 enrolled Fujian Cancer Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Based on the previous HMORCT09-2, the results show that IV PCA for analgesia maintenance improvements control of severe cancer pain after successful titration. Therefore, a study is planned to further explore the difference of efficacy and safety between PCA with continuous + bolus dose versus bolus-only.

Timeline

Start
2021-07-01
Primary completion
2024-05-01
Completion
2024-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydromorphone Other / unclassified — Intravenous
Comparator Morphine Other / unclassified — Oral

Indications

No indication recorded.